Donna M. Small - Concepedia

Author

Donna M. Small

Also Known As

D M Small, D Small, D. Small, D.M. Small, Donna M Small, Donna M. Small, Donna Small, Donna Small (362075), Simon J Leedham

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Queen's University Belfast Children's Health Ireland at Crumlin University of Birmingham Royal Victoria Hospital Amgen (United States)

About

Donna M. Small is an author at Queen's University Belfast specializing in medicine, pathology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	178
2	Engineering	1	1	68
3	Health Sciences	1	1	35
4	Natural Sciences	1	1	24
5	Biochemistry	1	1	24

Donna M. Small

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Targeting Siglecs with a sialic acid–decorated nanoparticle abrogates inflammation Shaun Spence, Michelle K. Greene, François Fay, Science Translational Medicine	2015	174
Innate Lymphoid Cells Are the Predominant Source of IL-17A during the Early Pathogenesis of Acute Respiratory Distress Syndrome Roshell Muir, Megan Osbourn, Alice V. Dubois, American Journal of Respiratory and Critical Care Medicine	2015	114
Antibody-Mediated Inhibition of Cathepsin S Blocks Colorectal Tumor Invasion and Angiogenesis Roberta E. Burden, Julie A. Gormley, Thomas J. Jaquin, Clinical Cancer Research	2009	108
Cathepsin S from both tumor and tumor‐associated cells promote cancer growth and neovascularization Donna M. Small, Roberta E. Burden, Jakub Jaworski, International Journal of Cancer	2013	98
Conatumumab (AMG 655) coated nanoparticles for targeted pro-apoptotic drug delivery François Fay, Kirsty M. McLaughlin, Donna M. Small, Biomaterials NanoparticlesNanomedicineDrug TargetingEngineeringTherapeutic Nanomaterials	2011	68
Clearance of intracellular Klebsiella pneumoniae infection using gentamicin-loaded nanoparticles Lai Jiang, Michelle K. Greene, José Luis Insua, Journal of Controlled Release NanomedicineKlebsiella PneumoniaeNano-drug DeliveryGentamicin-loaded NanoparticlesDrug Resistance	2018	67
Antibody Targeting of Cathepsin S Inhibits Angiogenesis and Synergistically Enhances Anti-VEGF Claire Ward, Diana Kuehn, Roberta E. Burden, PLoS ONE	2010	62
Nanoencapsulation of ABT-737 and camptothecin enhances their clinical potential through synergistic antitumor effects and reduction of systemic toxicity Daniela Schmid, Gavin E. Jarvis, François Fay, Cell Death and Disease	2014	55
IL4Rα Signaling Abrogates Hypoxic Neutrophil Survival and Limits Acute Lung Injury Responses <i>In Vivo</i> A.J. Harris, Ananda S. Mirchandani, Ruairi Lynch, American Journal of Respiratory and Critical Care Medicine	2019	52
Targeting of cathepsin S reduces cystic fibrosis-like lung disease Donna M. Small, Ryan Brown, Declan Doherty, European Respiratory Journal	2019	47

Page 1